Live Analyst Rating Changes 38454 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Andrew Mok CFA
BARC

Andrew Mok CFA

Barclays
Wall Street Analyst
★★★☆☆
#1361
on 13Foresight · ranked by our own returns
49%
Success Rate
+2.5%
Average Return
48 of 97 calls profitable · +31.4% vs benchmark
S&P 500 (SPY)
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 49% of Andrew Mok CFA's ratings turned a profit when each position was held for 1 year — averaging +2.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

124 Buy 72 Hold 25 Sell
Andrew's Stock Coverage 26 ratings · 2026-10-07
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
ADUS
Addus Homecare
 Oct 07, 2026 SELL Strong Buy
+13.4% avg upside
19 analysts
$96.00
15.12% Downside
 · ·
AVAH
Aveanna Healthcare Holdings
 Oct 07, 2026 BUY Buy
-7.0% avg upside
19 analysts
$15.00
22.84% Upside
 · ·
ASTH
Astrana Health
 Oct 07, 2026 BUY Strong Buy
+51.1% avg upside
17 analysts
$53.00
43.25% Upside
 · ·
SGRY
Surgery Partners
 Oct 07, 2026 HOLD Strong Buy
+78.3% avg upside
18 analysts
$14.00
4.42% Upside
 · ·
ELV
Elevance Health
 Oct 07, 2026 BUY Strong Buy
+13.1% avg upside
33 analysts
$469.00
17.27% Upside
 +0.0% ·
UHS
Universal Health
 Oct 07, 2026 HOLD Buy
+9.2% avg upside
22 analysts
$168.00
5.13% Downside
 · ·
HCA
HCA Healthcare
 Oct 07, 2026 HOLD Strong Buy
-5.7% avg upside
37 analysts
$387.00
10.39% Downside
 +0.0% ·
DVA
DaVita
 Oct 07, 2026 HOLD Buy
-4.6% avg upside
17 analysts
$224.00
24.11% Upside
 +0.0% ·
ALHC
Alignment Healthcare
 Oct 06, 2026 HOLD Strong Buy
+142.8% avg upside
19 analysts
$10.00
19.44% Upside
 +0.0% ·
CI
Cigna
 Oct 01, 2026 HOLD Strong Buy
+25.6% avg upside
30 analysts
$310.00
12.93% Upside
 +2.4% ·
HUM
Humana
 Sep 25, 2026 BUY Buy
+4.3% avg upside
34 analysts
$515.00
27.29% Upside
 -2.4% ·
CNC
Centene
 Sep 17, 2026 BUY Buy
+11.4% avg upside
29 analysts
$80.00
23.78% Upside
 -3.1% ·
OSCR
Oscar Health
 Sep 17, 2026 BUY Hold
-17.8% avg upside
16 analysts
$49.00
51.50% Upside
 +1.1% ·
BKD
Brookdale Senior Living
 Sep 10, 2026 BUY Strong Buy
+33.0% avg upside
11 analysts
$17.00
55.90% Upside
 -11.6% ·
UNH
UnitedHealth
 Sep 10, 2026 BUY Strong Buy
+21.4% avg upside
36 analysts
$441.00
17.14% Upside
 -2.6% ·
LMRI
Lumexa Imaging Holdings, Inc.
 Aug 28, 2026 BUY Strong Buy
+78.6% avg upside
9 analysts
$13.00
21.37% Upside
 -5.8% ·
PRVA
Privia Health Group
 Aug 28, 2026 HOLD Strong Buy
+57.1% avg upside
26 analysts
$24.00
18.43% Upside
 -3.7% ·
RDNT
Radnet
 Aug 28, 2026 BUY Strong Buy
+18.4% avg upside
11 analysts
$79.00
12.45% Upside
 -9.3% ·
GMRS
GMR Solutions, Inc. Class A
 Aug 28, 2026 BUY Strong Buy
+82.4% avg upside
9 analysts
$16.00
56.82% Upside
 -21.5% ·
ACHC
Acadia Healthcare
 Aug 28, 2026 HOLD Strong Buy
+54.4% avg upside
18 analysts
$32.00
10.16% Upside
 -1.7% ·
AGL
Agilon Health
 Aug 06, 2026 HOLD Buy
-16.9% avg upside
26 analysts
$111.00
33.14% Upside
 -2.9% ·
EHC
Encompass Health
 Aug 06, 2026 BUY Strong Buy
-4.5% avg upside
23 analysts
$144.00
15.55% Upside
 -0.0% ·
CVS
CVS Health
 Aug 06, 2026 BUY Strong Buy
+24.0% avg upside
39 analysts
$108.00
24.99% Upside
 -10.1% ·
MOH
Molina Healthcare
 Jul 24, 2026 SELL Hold
+21.4% avg upside
26 analysts
$180.00
7.73% Downside
 +1.4% ·
THC
Tenet Healthcare
 Jul 24, 2026 BUY Strong Buy
-6.3% avg upside
29 analysts
$271.00
4.85% Upside
 +11.3% ·
CYH
Community Health
 Jul 23, 2026 SELL Sell
+48.2% avg upside
20 analysts
$2.50
8.82% Downside
 +0.7% ·
🔒 21 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Andrew Mok CFA — Frequently Asked Questions
How accurate are Andrew Mok CFA's stock ratings?
Based on the calls 13Foresight could measure, about 49% of Andrew's ratings were profitable over a one-year hold, with an average return of +2.5% per rating, or +31.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Andrew ranked on 13Foresight?
Andrew Mok CFA is currently ranked #1361 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Andrew cover?
Andrew most recently has ratings on ADUS, AVAH, ASTH, SGRY, ELV, UHS, HCA, DVA, ALHC, CI, HUM, CNC and 14 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.